NasdaqGS - Nasdaq Real Time Price USD
Beam Therapeutics Inc. (BEAM)
19.62
-0.25
(-1.26%)
As of 12:35:18 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BELLON CHRISTINE Officer | Sale | Apr 1, 2025 | 117,294 |
| BURRELL TERRY-ANN Chief Financial Officer | Stock Award(Grant) | Apr 26, 2024 | 82,637 |
| CAVANAGH BETHANY J Officer and Treasurer | Sale | Apr 1, 2025 | 44,512 |
| CIARAMELLA GIUSEPPE President | Sale | Apr 1, 2025 | 190,216 |
| EMANY SRAVAN KUMAR Chief Financial Officer | Stock Award(Grant) | Dec 31, 2024 | 80,000 |
| EVANS JOHN M. Chief Executive Officer | Sale | Apr 1, 2025 | 1,089,250 |
| FMR, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 14, 2024 | -- |
| SIMON AMY Officer | Sale | Apr 2, 2025 | 65,742 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
8.11
+0.25%
PRME Prime Medicine, Inc.
1.7850
+0.28%
EDIT Editas Medicine, Inc.
1.5750
+0.96%
CRSP CRISPR Therapeutics AG
38.92
+0.99%
VERV Verve Therapeutics, Inc.
5.71
+4.39%
CRBU Caribou Biosciences, Inc.
0.8391
-0.38%
FATE Fate Therapeutics, Inc.
1.3745
+3.35%
DYN Dyne Therapeutics, Inc.
11.14
+3.34%
RNA Avidity Biosciences, Inc.
29.99
-2.27%
SRPT Sarepta Therapeutics, Inc.
61.30
+3.04%